Loading the records…
Loading the records…
CDC · CDC OFFICE OF ACQUISITION SERVICES
CDC wants bids for "Non-Research Long-Term Care facility needed for the enrichment and socialization of Non-Human Primate colony". The work is in Atlanta, GA, USA. The original due date (Sep 14, 2026) has passed; check the latest amendment for the current one. In the last 2 years, similar work (matched on the agency only, a loose match) went to 10 or more companies, usually for about $785K per award.
Put together from the facts on this page; the details and sources are below.
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Every notice posted under solicitation 75D30126Q79062 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
111 award notices on SAM.gov in the last 24 months. Matched by: Same agency (CDC), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (107): middle half $242K to $7.0M, median $785K; range $14K to $4.5B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| POLOLEI SOLUTIONS, LLC | 5 | $3.3M | Jul 21, 2026 |
| GLAXOSMITHKLINE, LLC | 3 | $1.7B | Mar 27, 2026 |
| RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA | 3 | $9.8M | Jun 4, 2026 |
| MERCK SHARP & DOHME LLC · $MRK · $66.6B | 2 | $4.5B | Sep 14, 2026 |
| Pfizer New York NY 10001 USA | 2 | $1.2B | Jun 3, 2026 |
| SEQIRUS USA INC | 2 | $663.9M | Dec 31, 2024 |
| Moderna Princeton NJ 08540 USA | 2 | $314.2M | Jun 3, 2026 |
| SANOFI PASTEUR INC. | 2 | $233.3M | Dec 31, 2024 |
| ASTRAZENECA PHARMACEUTICALS LP | 2 | $61.0M | Dec 31, 2024 |
| Sanofi Swiftwater PA 18370 USA | 2 | $40.6M | Jun 3, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.